These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 26251471)

  • 41. A comparison of rat small intestinal insulin and insulin-like growth factor I receptors during fasting and refeeding.
    Ziegler TR; Almahfouz A; Pedrini MT; Smith RJ
    Endocrinology; 1995 Nov; 136(11):5148-54. PubMed ID: 7588253
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Reduced insulin-like growth factor I receptor and altered insulin receptor isoform mRNAs in normal mucosa predict colorectal adenoma risk.
    Santoro MA; Andres SF; Galanko JA; Sandler RS; Keku TO; Lund PK
    Cancer Epidemiol Biomarkers Prev; 2014 Oct; 23(10):2093-100. PubMed ID: 25017244
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Both IGF1R and INSR Knockdown Exert Antitumorigenic Effects in Prostate Cancer In Vitro and In Vivo.
    Ofer P; Heidegger I; Eder IE; Schöpf B; Neuwirt H; Geley S; Klocker H; Massoner P
    Mol Endocrinol; 2015 Dec; 29(12):1694-707. PubMed ID: 26452103
    [TBL] [Abstract][Full Text] [Related]  

  • 44. HASF (C3orf58) is a novel ligand of the insulin-like growth factor 1 receptor.
    Bareja A; Hodgkinson CP; Payne AJ; Pratt RE; Dzau VJ
    Biochem J; 2017 Feb; 474(5):771-780. PubMed ID: 28096202
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Insulin receptor isoforms and insulin-like growth factor receptor in human follicular cell precursors from papillary thyroid cancer and normal thyroid.
    Malaguarnera R; Frasca F; Garozzo A; Gianì F; Pandini G; Vella V; Vigneri R; Belfiore A
    J Clin Endocrinol Metab; 2011 Mar; 96(3):766-74. PubMed ID: 21123448
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Down-regulation of insulin receptor by antibodies against the type I insulin-like growth factor receptor: implications for anti-insulin-like growth factor therapy in breast cancer.
    Sachdev D; Singh R; Fujita-Yamaguchi Y; Yee D
    Cancer Res; 2006 Feb; 66(4):2391-402. PubMed ID: 16489046
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Repression of the insulin receptor promoter by the tumor suppressor gene product p53: a possible mechanism for receptor overexpression in breast cancer.
    Webster NJ; Resnik JL; Reichart DB; Strauss B; Haas M; Seely BL
    Cancer Res; 1996 Jun; 56(12):2781-8. PubMed ID: 8665514
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Quantitative Proteomics of Intestinal Mucosa From Male Mice Lacking Intestinal Epithelial Insulin Receptors.
    Jensen SR; Schoof EM; Wheeler SE; Hvid H; Ahnfelt-Rønne J; Hansen BF; Nishimura E; Olsen GS; Kislinger T; Brubaker PL
    Endocrinology; 2017 Aug; 158(8):2470-2485. PubMed ID: 28591806
    [TBL] [Abstract][Full Text] [Related]  

  • 49. IR and IGF-1R expression affects insulin induced proliferation and DNA damage.
    Othman EM; Altabaa T; Hintzsche H; Stopper H
    Toxicol In Vitro; 2017 Mar; 39():68-74. PubMed ID: 27884723
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A mechanism for cell size regulation by the insulin and insulin-like growth factor-I receptors.
    Sun H; Tu X; Baserga R
    Cancer Res; 2006 Dec; 66(23):11106-9. PubMed ID: 17145851
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Caveolin-1 increases glycolysis in pancreatic cancer cells and triggers cachectic states.
    Hu L; Xu X; Li Q; Chen X; Yuan X; Qiu S; Yao C; Zhang D; Wang F
    FASEB J; 2021 Aug; 35(8):e21826. PubMed ID: 34320244
    [TBL] [Abstract][Full Text] [Related]  

  • 52. In vitro and in vivo antitumor effects of the dual insulin-like growth factor-I/insulin receptor inhibitor, BMS-554417.
    Haluska P; Carboni JM; Loegering DA; Lee FY; Wittman M; Saulnier MG; Frennesson DB; Kalli KR; Conover CA; Attar RM; Kaufmann SH; Gottardis M; Erlichman C
    Cancer Res; 2006 Jan; 66(1):362-71. PubMed ID: 16397250
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Expression of insulin/IGF-I hybrid receptors is increased in skeletal muscle of patients with chronic primary hyperinsulinemia.
    Federici M; Lauro D; D'Adamo M; Giovannone B; Porzio O; Mellozzi M; Tamburrano G; Sbraccia P; Sesti G
    Diabetes; 1998 Jan; 47(1):87-92. PubMed ID: 9421379
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Insulin receptor isoform switching in intestinal stem cells, progenitors, differentiated lineages and tumors: evidence that IR-B limits proliferation.
    Andres SF; Simmons JG; Mah AT; Santoro MA; Van Landeghem L; Lund PK
    J Cell Sci; 2013 Dec; 126(Pt 24):5645-56. PubMed ID: 24127567
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical and functional characteristics of the human Arg59Ter insulin-like growth factor i receptor (IGF1R) mutation: implications for a gene dosage effect of the human IGF1R.
    Raile K; Klammt J; Schneider A; Keller A; Laue S; Smith R; Pfäffle R; Kratzsch J; Keller E; Kiess W
    J Clin Endocrinol Metab; 2006 Jun; 91(6):2264-71. PubMed ID: 16569742
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Insulin-like growth factor signaling regulates zebrafish embryonic growth and development by promoting cell survival and cell cycle progression.
    Schlueter PJ; Peng G; Westerfield M; Duan C
    Cell Death Differ; 2007 Jun; 14(6):1095-105. PubMed ID: 17332774
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Aldosterone induces vascular insulin resistance by increasing insulin-like growth factor-1 receptor and hybrid receptor.
    Sherajee SJ; Fujita Y; Rafiq K; Nakano D; Mori H; Masaki T; Hara T; Kohno M; Nishiyama A; Hitomi H
    Arterioscler Thromb Vasc Biol; 2012 Feb; 32(2):257-63. PubMed ID: 22173225
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Elucidating the Biological Roles of Insulin and Its Receptor in Murine Intestinal Growth and Function.
    Jensen SR; Wheeler SE; Hvid H; Ahnfelt-Rønne J; Hansen BF; Nishimura E; Olsen GS; Brubaker PL
    Endocrinology; 2017 Aug; 158(8):2453-2469. PubMed ID: 28591779
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Both epidermal growth factor and insulin-like growth factor receptors are dispensable for structural intestinal adaptation.
    Sun RC; Diaz-Miron JL; Choi PM; Sommovilla J; Guo J; Erwin CR; Warner BW
    J Pediatr Surg; 2015 Jun; 50(6):943-7. PubMed ID: 25818318
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Distribution of insulin receptor and insulin-like growth factor-1 receptor in the digital laminae of mixed-breed ponies: an immunohistochemical study.
    Burns TA; Watts MR; Weber PS; McCutcheon LJ; Geor RJ; Belknap JK
    Equine Vet J; 2013 May; 45(3):326-32. PubMed ID: 22924550
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.